Gentian Diagnostics AB is part of the Gentian group. We serve the Swedish market with products from Gentian as well as products from other manufacturers. Gentian Diagnostics AB works closely with Swedish and International universities and hospitals on a number of research and innovation projects.
|fCAL||BÜHLMANN fCAL® turbo allows very rapid and flexible random access use, as well as being the ideal solution for high throughput applications in the routine laboratory. The assay can be applied on all automated platforms in clinical chemistry and allows short turnaround time from stool sample to reportable result.|
|Plasma Calprotectin||The first Particle-Enhanced Turbidimetric Immunoassay (PETIA) for quantitative analysis of total calprotectin in plasma. The assay performs in only 10 minutes. It can be applied on a wide range of automated clinical chemistry analysers. GCal measures calprotectin in plasma in the diagnosis of inflammation.|
|Quantum Blue CRP||Quantum Blue CRP allows determination of serum CRP within 22 minutes. It is an ideal tool to accompany the calprotectin determination for establishing an Inflammatory Bowel Disease (IBD) patient inflammation profile during the course of the disease. The combination of these two markers has shown to increase the specificity for detecting inflammation in Crohn’s disease.|
|Quantum Blue MRP8/14||MRP8/14 is an early and sensitive inflammation marker. It is released immediately in response to local inflammation. In contrast, other inflammatory markers are generated by downstream pathways and require de novo synthesis. Therefore, MRP8/14 is an ideal target for monitoring disease activity of Rheumatoid Arthritis. The assays allow for precise and sensitive measurement of this important marker.|
|Quantum Blue Calprotectin Ascites||Quantum Blue Calprotectin Ascites. The measurement of calprotectin in ascitic fluid provides reliable and rapid results. It provides a solution for point of care detection of spontaneous bacterial peritonitis, which is an important cause of morbidity and mortality in cirrhotic patients with ascites.|
|Quantum Blue Infliximab||Quantum Blue® Infliximab This biologic drug is a therapeutic monoclonal antibody. It acts as an antagonist to TNF alpha, thus effectively blocks the inflammatory process in numerous chronic inflammatory diseases like Crohn’s disease, ulcerative colitis and inflammatory arthritis. It is the first rapid test to measure infliximab trough levels in patient’s serum to allow immediate decision making for potential drug dose adjustments.|
|Quantum Blue Adalimumab||The biologic drug Adalimumab is a therapeutic monoclonal antibody. It acts as an antagonist to TNF alpha, thus effectively blocks the inflammatory process in numerous chronic inflammatory diseases like Crohn’s disease, ulcerative colitis and inflammatory arthritis. The BÜHLMANN Quantum Blue® Adalimumab is the first rapid test to measure adalimumab trough levels in patient’s serum to allow immediate decision making for potential drug dose adjustments.|
|NGAL||A new Particle-Enhanced Turbidimetric Immunoassay (PETIA) for in vitro diagnostic testing of Neutrophil Gelatinase-Associated Lipocalin (NGAL) in human urine and plasma samples. The assay performs in only 10 minutes. It can be applied on a wide range of automated clinical chemistry analysers.|
|CALEX® Cap Stool Extraction Devices||CALEX® Cap - Stool Extraction. An efficient, convenient and hygienic extraction of stool samples. Its simple design makes it an ideal extraction device characterised not only by high safety but also by offering high stability of stool samples. Furthermore, the CALEX® Cap is fully compatible with Total Laboratory Automation (TLA) solutions increasing the speed of sample processing and reducing hands-on time.|
More information about Bühlmann www.buhlmannlabs.ch
Please fill out the form below.